News

Company has announced that the study of REOLYSIN® in combination with FOLFOX6 bevacizumab and pembrolizumab in female patients with KRAS-mutant colorectal cancer metastatic to the liver is now active.

Collaboration aims to employ powerful new approaches for the determination of high-resolution X-ray structures of GPCRs to discover new drug lead compounds.

A European study led by Umeå University Professor Lars Nyberg, has shown that the dopamine D2 receptor is linked to the long-term episodic memory, which function often reduces with age and due to dementia.

Cancer genomic profile information from 18,000 adult cancer patients will be added to the database.

New proteomic study to develop advanced resource for precision medicine research by using Microflow SWATH® Acquisition for HT industrialized proteomics.

Company has announced that Evotec has selected Genedata Screener® as a data management platform solution for its drug discovery research.

Investment will fund ongoing clinical trials in lung and colon cancer screening.

Company has entered into an agreement with Illumina for development and commercialization of sequencing-based companion diagnostics in support of biopharma drug development program(s).

Partnership aims to make Guardant360®, non-invasive genomic sequencing test for patients with advanced cancer, widely available to oncologists and patients in Israel.

The STARPlatform will enable GLASS to manage whole exome and genome sequencing data across multiple research centers.